BIO-Europe Spring® 2016: CEVEC CEO talks US deals to expand business

April 28, 2016
Frank Ubags, CEO of CEVEC—a company offering industrial scale production of viral vectors for gene therapy firms—speaks with Scrip's Lucie Ellis about the types of deals the platform technology company is seeking and what is coming up for CEVEC in 2016. He also highlights a deal the company is looking to solidify in the coming weeks that will expand its activities in the US.
Previous Video
BIO-Europe Spring® 2016: QureTech Bio explains novel approach to antibiotic development
BIO-Europe Spring® 2016: QureTech Bio explains novel approach to antibiotic development

Dr. Fritiof Pontén, CEO of QureTech Bio—one of Sweden's youngest biotech companies—talks with Mike Ward, gl...

Next Video
BIO-Europe Spring® 2016: Getting to know EUSA Pharma 2.0
BIO-Europe Spring® 2016: Getting to know EUSA Pharma 2.0

EUSA Pharma, initially formed in 2006 but later acquired by Jazz Pharmaceuticals in 2012, was reborn last y...